Announcements Trials

Browse Landscape

Status

No longer available 1

Sponsor Class

Study Type

Interventional 4 Expanded_access 1

Sponsor

Cancer Type

Conditions

Interventions

tazemetostat 2 regorafenib 2 nirogacestat 2 avapritinib 2 Trabectedin 2 selinexor 1 ripretinib 1 omburtamab I-131 1 olaratumab 1 mifamurtide 1 glucarpidase 1 ganitumab 1 fludarabine phosphate 1 balstilimab 1 anlotinib 1 Whole-Body Irradiation 1 Tacrolimus 1 TH 302 1 Sunitinib 1 Proton Pump Inhibitors 1 Mycophenolic Acid 1 Imatinib Mesylate 1 Hydrocortisone 1 FANG vaccine 1 Everolimus 1 DOXO-EMCH 1 Cytarabine 1 Cord Blood Stem Cell Transplantation 1 Carboxypeptidases 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × TH 302 × Sarcoma × Clear all

NCT02712567 2016-10-13

SARC021C: A Continuation Study of TH-CR-406/SARC021

Sarcoma Alliance for Research through Collaboration

No longer available

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡